![]() |
![]() |
![]() |
![]() |
![]() |
Individual samples Samples available for
cancer research
|
||||
Natural products repository Marine and plant samples available
|
||||
Radiolabeled materials More than 100 labeled
samples for research purposes
|
||||
Screening Services | ||||
Discreet screening agreement Intellectual
property issues
|
||||
Non-proprietary |
||||
3-cell line screen
|
||||
Proprietary via CRADAs
|
||||
Hollow fiber assay
|
||||
Data from Human Tumor Cell Line Assay
|
||||
Development
|
||||
Synthetic chemistry and GMP bulk production
|
||||
Master toxicology protocols
|
||||
|
||||
Membership of the BRB Oversight Committee
|
||||
Process and procedures
|
||||
Drug Development Group (DDG) Entry into the NCI clinical trials network at several stages of development |
||||
Stages of development
|
||||
Grants and Contracts Operations Branch
|